Take part in the debate and discuss what can can be done to boost actions to tackle AMR at EU level.
Tiemo Wölken MEP, Vice-Chair of the MEP Interest Group on Antimicrobial Resistance, S&D, Germany
Helle Aagaard, Deputy Director, ReAct Europe
Tim Jinks, Head of the Drug-Resistant Infections Programme, The Wellcome Trust
Marc Gitzinger, Vice-President, BEAM Alliance
Willo Brock, Senior Vice-President of External Affairs, TB Alliance
Zoltán Massay-Kosubek, Policy Manager, European Public Health Alliance
Jean-Yves Stenuick, Pharmaceuticals Policy & Projects Officer, Health Care Without Harm (HCWH) Europe
Join us to discuss
How can the development of new needs-driven models to finance and stimulate antibiotic R&D be supported?
How can the EU promote R&D models that ensure responsible use of and equitable and affordable access to antibiotics?
How can the Pharmaceutical Strategy be a game changer and contribute to fixing the antibiotic innovation pipeline?
How can the EU raise more awareness on AMR and how can we prevent the misuse and overuse of antibiotics on the ground?
Date and time: 17 November 2020 – 11:00-12:00 CET
Conference link here.